Survey of the efficacy and quality of some brands of the antibiotics sold in Calabar Metropolis, South-south region of Nigeria

Scientific Research and Essays

Volumn 5, Issue 4, 2010, Pages 395-406

  Nkang, A O ^a   Okonko, I O ^a   Lennox, J A ^b   Babalola, E T ^c   Adewale, O G ^d   Motayo, B O ^a,e   Mejeha, O K ^f   Adekolurejo, O A ^g   Amande, J T ^g,h  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF CALABAR   (Nigeria)

^c Crawford University   (Nigeria)

^d OLABISI ONABANJO UNIVERSITY   (Nigeria)

^e FEDERAL MEDICAL CENTER   (Nigeria)

^f FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^g UNIVERSITY OF IBADAN   (Nigeria)

^h UNIVERSITY OF UYO   (Nigeria)

Author keywords

Active ingredients; Antibiotics; Efficacy; Quality; Selective toxicity; Survey; Zones of inhibition

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 77949295081     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Adebayo A (2000). Antibiotics. J. Assoc. Med. Lab. Sci. Nig. 149(18): 19-25.
2. Adejoh LM (2000). Studies on antibiotic efficacy. J. Nig. Med. Assoc. 18(15): 12-20.
3. Aiyegoro OA, Igbinosa OO, Ogunmwonyi IN, Odjadjare EE, Igbinosa OE, Okoh AI (2007). Incidence of urinary tract infections (UTI) among children and adolescents in Ile-Ife, Nigeria. Afr. J. Microbiol. Res. 1: 013-019.
4. Akpan UE (1992). Antibiotic Usage: A need for an antibiotic Policy in Nigeria. Pharm. World J. 19(2): 42-44.
5. Alos JI, Gómez-Garcés JL, García-Bermejo I, García-Gómez JJ, Gonzalez-Palacios R, Padilla B (1993). The prevalence of Escherichia coli susceptibility to quinolone and other antibiotics in community-acquired bacteriurias in Madrid. Med. Clin. (Barc), 101: 87-90.
6. Arrow K, Panosian C, Gelband H (2004). Saving lives, buying time. Economics of malaria drugs in an age of resistance. Washington: National Academies Press.
7. Bates I, Fenton C, Gruber J, Lalloo D, Medina Lara A, Squire SB, Theobald S (2004). Vulnerability to malaria, tuberculosis and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect. Dis. 4: 267-277.
8. Baur AW, Kirby WM, Sherris JC, Jurek M (1996). Antibiotic susceptibility testing by a standard single disc method. Am. J. Clin. Pathol. 451: 493-496.
9. Cheebrough M (2000). Antimicrobial sensitivity Testing. In: District Laboratory Practice in Tropical Countries (part 2), Low price edition. Cambridge University Press, United Kingdom pp. 132-143.
10. Cheesbrough M (2002). Medical laboratories manual for tropical countries. Tropical Health Technology and Butterworth London 2: 479.
11. Cheesbrough M (2003). Medical Laboratory Manual. Tropical Health Technology, Low priced Edition. Doddington, Cambridgeshire, England pp. 20-35.
12. Cheesbrough M (2006). District Laboratory Practice in Tropical Countries. Cambridge University Press p. 434.
13. Christiaen TH, Heytens S, Verichraegen G, DeMeyers, DeMaeseneer J (1998). Which bacteria are found among Belgian women with uncomplicated urinary tract infections in primary health care and what is their sensitivity pattern annually 95-96. Act. Clin. Belg. 53(3): 184-188.
14. Coyle MB (2005). Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology Press, Washington D.C. pp. 25-39.
15. Dixon B (1994). Power unseen: how microbes rule the world. New York: WH Freeman.
16. Ebie MY, Kandakai-Olukemi YT, Ayanbadejo J, Tanyigna KB (2001). Urinary Tract Infections in a Nigerian Military Hospital. Nig. J. Microbiol. 15(1): 31-37.
17. Finegold SM, William JM, Elryn GS (1978). Diagnostic Microbiology. CV. Mosby Company, Saint Louis: USA pp. 385-399.
18. Florey HW (1998). The place of routine analysis and quality control in checking and eradication of fake drugs. Pharm. World J. 15(11): 19-27.
19. Goldraichi NP, Manfroi A (2002). Febrile urinary infection. Escherichia coli susceptibly to oral antimicrobials Paediatr. Nephrol. 17(3): 173-176.
20. Hoel D, Williams DN (1997). Antibiotics: Past, present and future-Unearthing nature's magic bullets. Postgraduate Med. 101: 1.
21. Jolt JG, Krieg NR, Sneath PHA, Stanley JT, Williams ST (1994). Bergey's manual of systematic bacteriology, 9th edn. Williams & Wilkins Co. Baltimore, Maryland p. 786.
22. Melmon BP, Morcelli HF (1989). title typecontributorBasic Principles and therapeutics/title. Textbook of Clinical Pharmacology, 3rd edition, Macmillan Publishing Company Inc, New York. pp. 65-125, 208-403, 405-409.
23. National Committee for Clinical Laboratory Standards (NCCLS) (2002). Performance standards for antimicrobial susceptibility testing: twelfth informational supplement. NCCLS document M100-S12. PA, USA.
24. Nnela KS, Cox KT (1988). Potency deterioration of benzyl penicillin, chloramphenicol and tetracycline. Ann. Rev. Med. Microbiol. 121(26): 166-172.
25. Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA (2007). Growing problem of multidrug-resistant enteric pathogens in Africa. Emerging Infectious Diseases 13(11): 1640-1646.
26. Okonko IO, Donbraye-Emmanuel OB, Ijandipe LA, Ogun AA, Adedeji AO, Udeze AO (2009a). Antibiotics Sensitivity and Resistance Patterns of Uropathogens to Nitrofurantoin and Nalidixic Acid in Pregnant Women with Urinary Tract Infections in Ibadan, Nigeria. Middle-East J. Sci. Res. 4(2): 105-109.
27. Okonko IO, Fajobi EA, Ogunnusi TA, Ogunjobi AA, Obiogbolu CH (2008). Antimicrobial Chemotherapy and Sustainable Development: The Past, the Current Trend and the future. Afr. J. Biomed. Res. 11(3): 235-250.
28. Okonko IO, Soleye FA, Amusan TA, Ogun AA, Ogunnusi TA, Ejembi J, Egun OC, Onajobi BI (2009b). Incidence of Multi-Drug Resistance (MDR) Organisms in Abeokuta, Southwestern Nigeria. Global J. Pharmacol. (in press)
29. Olowu WA, Oyetunji TG (2003). Nosocomial significant bacteriuria prevalence and pattern of bacterial pathogens among children hospitalized for non-infective urinary tract disorders. West Afr. J. Med. 22(1): 72-75.
30. Oyeleke SB, Manga SB (2008). Essentials of Laboratory Practicals in Microbiology Tobest publisher, Minna. Nigeria pp. 36-75.
31. Pelczar MJ, Chan ECS, Krieg NR (1993). Antibiotics and other chemotherapeutic agents. Textbook of Microbiology, 5th edition. Tata Mc Graw-Hill Publishing Company Limited, New Delhi pp. 510-525.
32. Pelczar MJ, Reid RD (1998). Activities of antimicrobial agents in Microbiology. In: Antibiotic Drugs 87(6): 74-83.
33. Popoola A (2001). Fake Drugs. Nigerian Association of Industrial Pharmacist committee to enlighten the public on the issue of drug distribution, fake adulterated and substandard drugs in Nigeria. The Punch, Tuesday, 23rd October, 2001.
34. Pratt WB, Fekety R (1986). Drug Interaction. The Antimicrobial Drugs. Oxford University Press, New York pp. 241-248.
35. Prescott LM, Harley JP, Klein AD (2005). Drug Resistance, WCB McGraw-Hill, Microbiology 6th International Edition p. 1212.
36. Reish O, Ashkenazi S, Naor N, Samra Z, Merlob P (1993). An outbreak of multiresistant Klebsiella in a neonatal intensive care unit. J. Hosp. Infect. 25(4): 287-291.
37. Schellenberg JA, Victora CG, Mushi A, de Savigny D, Schellenberg D, Mshinda H, Bryce J (2003). Inequities among the very poor: health care for children in rural southern Tanzania. Lancet 361: 561-566.
38. Singh JA, Upshur R, Padayatchi N (2007). XDR-TB in South Africa: no time for denial or complacency. PLoS Med. 4: e50.